ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/11/29 | 1,370 | 1,410 | 1,370 | 1,392 | +22 | +1.6% | 347,000 |
2019/11/28 | 1,432 | 1,448 | 1,370 | 1,370 | -82 | -5.6% | 823,100 |
2019/11/27 | 1,501 | 1,539 | 1,424 | 1,452 | -19 | -1.3% | 1,448,400 |
2019/11/26 | 1,450 | 1,485 | 1,435 | 1,471 | +33 | +2.3% | 524,900 |
2019/11/25 | 1,412 | 1,453 | 1,403 | 1,438 | +18 | +1.3% | 540,700 |
2019/11/22 | 1,388 | 1,430 | 1,383 | 1,420 | +43 | +3.1% | 572,000 |
2019/11/21 | 1,365 | 1,435 | 1,334 | 1,377 | +15 | +1.1% | 799,400 |
2019/11/20 | 1,370 | 1,388 | 1,345 | 1,362 | -18 | -1.3% | 237,500 |
2019/11/19 | 1,334 | 1,385 | 1,326 | 1,380 | +40 | +3% | 322,400 |
2019/11/18 | 1,302 | 1,340 | 1,292 | 1,340 | +40 | +3.1% | 210,000 |
2019/11/15 | 1,287 | 1,305 | 1,286 | 1,300 | +9 | +0.7% | 171,400 |
2019/11/14 | 1,296 | 1,312 | 1,291 | 1,291 | -11 | -0.8% | 173,000 |
2019/11/13 | 1,320 | 1,325 | 1,300 | 1,302 | -23 | -1.7% | 223,700 |
2019/11/12 | 1,321 | 1,333 | 1,311 | 1,325 | -5 | -0.4% | 156,600 |
2019/11/11 | 1,334 | 1,388 | 1,315 | 1,330 | +19 | +1.4% | 566,700 |
2019/11/08 | 1,334 | 1,349 | 1,311 | 1,311 | -29 | -2.2% | 261,000 |
2019/11/07 | 1,353 | 1,353 | 1,319 | 1,340 | -7 | -0.5% | 230,700 |
2019/11/06 | 1,348 | 1,356 | 1,328 | 1,347 | +6 | +0.4% | 261,000 |
2019/11/05 | 1,357 | 1,365 | 1,341 | 1,341 | -9 | -0.7% | 198,700 |
2019/11/01 | 1,331 | 1,353 | 1,320 | 1,350 | +19 | +1.4% | 289,900 |
2019/10/31 | 1,299 | 1,333 | 1,291 | 1,331 | +36 | +2.8% | 393,100 |
2019/10/30 | 1,335 | 1,335 | 1,292 | 1,295 | -29 | -2.2% | 342,800 |
2019/10/29 | 1,310 | 1,336 | 1,306 | 1,324 | +4 | +0.3% | 200,100 |
2019/10/28 | 1,322 | 1,342 | 1,299 | 1,320 | -10 | -0.8% | 411,800 |
2019/10/25 | 1,392 | 1,396 | 1,324 | 1,330 | -46 | -3.3% | 514,100 |
2019/10/24 | 1,345 | 1,390 | 1,335 | 1,376 | +31 | +2.3% | 464,300 |
2019/10/23 | 1,339 | 1,363 | 1,325 | 1,345 | +20 | +1.5% | 211,100 |
2019/10/21 | 1,311 | 1,334 | 1,308 | 1,325 | +4 | +0.3% | 137,300 |
2019/10/18 | 1,312 | 1,347 | 1,297 | 1,321 | +13 | +1% | 307,000 |
2019/10/17 | 1,285 | 1,313 | 1,270 | 1,308 | +27 | +2.1% | 227,300 |
2019/10/16 | 1,326 | 1,329 | 1,281 | 1,281 | -44 | -3.3% | 191,100 |
2019/10/15 | 1,282 | 1,326 | 1,277 | 1,325 | +51 | +4% | 198,000 |
2019/10/11 | 1,300 | 1,307 | 1,272 | 1,274 | -23 | -1.8% | 228,100 |
2019/10/10 | 1,289 | 1,319 | 1,281 | 1,297 | -2 | -0.2% | 329,500 |
2019/10/09 | 1,335 | 1,337 | 1,298 | 1,299 | -49 | -3.6% | 358,700 |
2019/10/08 | 1,360 | 1,389 | 1,345 | 1,348 | -8 | -0.6% | 333,600 |
2019/10/07 | 1,351 | 1,361 | 1,327 | 1,356 | +15 | +1.1% | 219,100 |
2019/10/04 | 1,353 | 1,354 | 1,316 | 1,341 | +3 | +0.2% | 531,800 |
2019/10/03 | 1,359 | 1,373 | 1,333 | 1,338 | -47 | -3.4% | 394,500 |
2019/10/02 | 1,350 | 1,395 | 1,343 | 1,385 | +5 | +0.4% | 376,000 |
2019/10/01 | 1,410 | 1,420 | 1,379 | 1,380 | -28 | -2% | 413,000 |
2019/09/30 | 1,419 | 1,431 | 1,397 | 1,408 | -6 | -0.4% | 491,100 |
2019/09/27 | 1,378 | 1,415 | 1,347 | 1,414 | +20 | +1.4% | 546,100 |
2019/09/26 | 1,423 | 1,442 | 1,384 | 1,394 | +1 | +0.1% | 1,056,200 |
2019/09/25 | 1,355 | 1,413 | 1,300 | 1,393 | +34 | +2.5% | 1,835,300 |
2019/09/24 | 1,210 | 1,449 | 1,210 | 1,359 | +203 | +17.6% | 4,645,300 |
2019/09/20 | 1,125 | 1,200 | 1,112 | 1,156 | +20 | +1.8% | 1,842,400 |
2019/09/19 | 1,159 | 1,215 | 1,114 | 1,136 | -25 | -2.2% | 2,317,600 |
2019/09/18 | 1,026 | 1,272 | 1,023 | 1,161 | +146 | +14.4% | 5,703,100 |
2019/09/17 | 986 | 1,028 | 985 | 1,015 | +13 | +1.3% | 641,100 |
1401~
1450
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
Chordia | 18,000円 | - | - | 0.00% | - | 3.83倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
セルソース | 62,300円 | - | - | 0.80% | 48.41倍 | 2.09倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム